These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
3667 related items for PubMed ID: 7365733
21. Enhanced in vitro macrophage cytotoxicity against interferon-treated B16 melanoma cells. Fleischmann CM, Fleischmann WR. J Biol Regul Homeost Agents; 1995; 9(4):139-45. PubMed ID: 8844338 [Abstract] [Full Text] [Related]
22. Enhancement of macrophage cytotoxicity to tumors and production of megakaryocyte-stimulating factors by microbial agents. Ralph P, Williams N, Nakoinz I, Jackson H, Ito M, Azuma I, Yamamura Y. Kekkaku; 1980 Nov; 55(11):499-503. PubMed ID: 6970296 [No Abstract] [Full Text] [Related]
23. Tissue damage caused by TNF and complement. Rothstein JL, Schreiber H. Immunol Ser; 1992 Nov; 56():453-81. PubMed ID: 1550872 [No Abstract] [Full Text] [Related]
24. Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats. Bonatto SJ, Folador A, Aikawa J, Yamazaki RK, Pizatto N, Oliveira HH, Vecchi R, Curi R, Calder PC, Fernandes LC. Cell Immunol; 2004 Nov; 231(1-2):56-62. PubMed ID: 15919370 [Abstract] [Full Text] [Related]
25. TNF revisited: TNF-independent antitumor activity in sera of mice sensitized with Propionibacterium acnes and challenged with lipopolysaccharide. Schwamberger G, Hammerl P, Ferber E, Freudenberg M, Galanos C. J Leukoc Biol; 2003 Dec; 74(6):1056-63. PubMed ID: 12960265 [Abstract] [Full Text] [Related]
26. Delayed hypersensitivity and neoplasia: in vitro studies with macrophage migration. Steiner T, Watne AL. Cancer Res; 1970 Aug; 30(8):2265-70. PubMed ID: 5459770 [No Abstract] [Full Text] [Related]
27. The specificity of rat natural killer cells and cytotoxic macrophages on solid tumor-derived target cells and selected variants. Brooks CG, Wayner EA, Webb PJ, Gray JD, Kenwrick S, Baldwin RW. J Immunol; 1981 Dec; 127(6):2477-83. PubMed ID: 7299133 [No Abstract] [Full Text] [Related]
32. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation. Schlager SI, Meltzer MS. J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233 [No Abstract] [Full Text] [Related]
33. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice. Robinson MK, Wheelock EF. J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990 [No Abstract] [Full Text] [Related]
34. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages. Dong Z, Qi X, Xie K, Fidler IJ. J Immunol; 1993 Sep 01; 151(5):2717-24. PubMed ID: 7689614 [Abstract] [Full Text] [Related]
35. [Immunological surveillance mechanism of a rat brain tumor model--study of peritoneal macrophages as tumoricidal effector cells (author's transl)]. Inoue K. No To Shinkei; 1980 Jun 01; 32(6):611-5. PubMed ID: 7459139 [No Abstract] [Full Text] [Related]
36. Activation of tumoricidal and/or suppressor macrophages: different stimulatory signals trigger either function both in vivo and in vitro. Taramelli D, Bagley MB, Holden HT, Varesio L. Adv Exp Med Biol; 1982 Jun 01; 155():487-92. PubMed ID: 6218736 [No Abstract] [Full Text] [Related]